Strides Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE939A01011
  • NSEID: STAR
  • BSEID: 532531
INR
964.90
-7.75 (-0.8%)
BSENSE

Nov 20

BSE+NSE Vol: 2.49 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 688428,
    "name": "Strides Pharma",
    "stock_name": "Strides Pharma",
    "full_name": "Strides Pharma Science Ltd",
    "name_url": "stocks-analysis/strides-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "964.90",
    "chg": -7.75,
    "chgp": "-0.8%",
    "dir": -1,
    "prev_price": "972.65",
    "mcapval": "8,930.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532531,
    "symbol": "STAR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE939A01011",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "2.49 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/strides-pharma-688428-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Strides Pharma Science Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/strides-pharma-science-ltd-is-rated-hold-4257810",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/StridesPharmaSc_mojoScore_4257810.png",
        "date": "2026-11-11 10:10:52",
        "description": "Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 October 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 11 November 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Strides Pharma Gains 5.63%: Key Events and Margin Pressures Shape Weekly Performance",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/strides-pharma-gains-563-key-events-and-margin-pressures-shape-weekly-performance-4245968",
        "imagepath": "",
        "date": "2026-10-31 16:03:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Stock opens strong at Rs.1,031.55 (+1.92%)</p>\n                    <p><strong>27 Oct:</strong> Intraday high of Rs.1,112 with 7.52% surge</p>\n                    <p><strong>30 Oct:</strong> Intraday low of Rs.989.3 amid price pressure</p>\n                    <p><strong>30 Oct:</strong> Flat quarterly performance reported with margin concerns</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,012.15</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,069.15</div><div c..."
      },
      {
        "title": "Strides Pharma Science Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/strides-pharma-science-ltd-is-rated-hold-4245356",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/StridesPharmaSc_mojoScore_4245356.png",
        "date": "2026-10-31 10:10:24",
        "description": "Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Strides Pharma Science Ltd Reports Flat Quarterly Performance Amid Margin Pressures",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/strides-pharma-science-ltd-reports-flat-quarterly-performance-amid-margin-pressures-4244815",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/StridesPharmaSc_fintrenddot_4244815.png",
        "date": "2026-10-30 11:00:19",
        "description": "Strides Pharma Science Ltd has reported a flat financial performance for the quarter ended September 2026, marking a notable shift from its previously positive growth trajectory. Despite achieving record-high sales and operating cash flows, the company’s margin expansion has stalled, leading to a downgrade in its Mojo Grade from Buy to Hold."
      },
      {
        "title": "Strides Pharma Science Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/strides-pharma-science-ltd-hits-intraday-low-amid-price-pressure-4244784",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/StridesPharmaSc_priceRelatedfactors_4244784.png",
        "date": "2026-10-30 10:51:59",
        "description": "Strides Pharma Science Ltd experienced significant intraday weakness on 30 Oct 2026, with its stock price touching a low of Rs 989.3, marking a decline of 9.85% from the previous close. The stock underperformed its sector and the broader market, reflecting immediate selling pressure and subdued market sentiment within the Pharmaceuticals & Biotechnology space."
      },
      {
        "title": "Strides Pharma Science Ltd Surges 7.52% to Day's High of Rs 1112 — Outperforms Sector by 6.73 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/strides-pharma-science-ltd-hits-intraday-high-with-752-surge-on-27-oct-2026-4241072",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/StridesPharmaSc_priceRelatedfactors_4241072.png",
        "date": "2026-10-27 12:01:37",
        "description": "The Sensex remained nearly flat, edging down just 0.01%, while Strides Pharma Science Ltd surged 7.52% on 27 Oct 2026, hitting an intraday high of Rs 1112. This 6.73 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a broad market move."
      },
      {
        "title": "Strides Pharma Falls 3.61%: 3 Key Factors Driving the Weekly Decline",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/strides-pharma-falls-361-3-key-factors-driving-the-weekly-decline-4228784",
        "imagepath": "",
        "date": "2026-10-17 16:01:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>12 Oct:</strong> Stock opens strong at ₹1,096.05 (+1.19%) amid technical upgrades</p>\n                    <p><strong>13 Oct:</strong> Mojo Grade upgraded to Buy; price peaks at ₹1,098.05 (+0.18%)</p>\n                    <p><strong>15 Oct:</strong> Technical momentum shifts to mildly bullish; price drops 2.14%</p>\n                    <p><strong>16 Oct:</strong> Week closes lower at ₹1,044.10 (-1.59%) despite Sensex gains</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,083.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">..."
      },
      {
        "title": "Strides Pharma Science Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/strides-pharma-science-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4225978",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/StridesPharmaSc_technicaldot_4225978.png",
        "date": "2026-10-15 08:02:48",
        "description": "Strides Pharma Science Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from a bullish to a mildly bullish trend. Despite a modest decline in the stock price, the company’s technical parameters reveal a complex interplay of bullish and bearish signals across weekly and monthly timeframes, warranting a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Strides Pharma Science Ltd Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/strides-pharma-science-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-4223777",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/StridesPharmaSc_mojoScore_4223777.png",
        "date": "2026-10-13 08:40:53",
        "description": "Strides Pharma Science Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, valuation metrics, financial trends, and overall quality. This upgrade, effective from 12 Oct 2026, is underpinned by robust quarterly results, sustained long-term growth, and bullish technical signals, positioning the small-cap pharmaceutical company favourably against its peers and broader market benchmarks."
      }
    ],
    "total": 97,
    "sid": "688428",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/strides-pharma-science-688428"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "18-Nov-2026",
      "details": "Notice of Postal Ballot seeking Shareholders approval for appointment of Mr. Biren Chandrakant Gabhawala as an Independent Director of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "02-Nov-2026",
      "details": "Transcript of Earnings Call pertaining of Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Oct-2026",
      "details": "Newspaper Advertisement - Unaudited Financial Results for the quarter and half year ended September 30 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Strides Pharma Science Ltd has declared <strong>50%</strong> dividend, ex-date: 31 Jul 26",
          "dt": "2026-07-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

18-Nov-2026 | Source : BSE

Notice of Postal Ballot seeking Shareholders approval for appointment of Mr. Biren Chandrakant Gabhawala as an Independent Director of the Company.

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

02-Nov-2026 | Source : BSE

Transcript of Earnings Call pertaining of Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

30-Oct-2026 | Source : BSE

Newspaper Advertisement - Unaudited Financial Results for the quarter and half year ended September 30 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Strides Pharma Science Ltd has declared 50% dividend, ex-date: 31 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available